https://pipelinereview.com/ALXN1840-FoCus-Phase-III-trial-in-Wilson-disease-met-primary-endpoint-demonstrating-improvement-in-copper-mobilisation-from-tissues/
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues